VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 36 filers reported holding VINCERX PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,940,602 | +25.0% | 1,492,771 | 0.0% | 0.68% | +32.4% |
| Q1 2023 | $1,552,482 | +2.0% | 1,492,771 | 0.0% | 0.51% | -14.2% |
| Q4 2022 | $1,522,626 | -26.1% | 1,492,771 | 0.0% | 0.60% | +3.8% |
| Q3 2022 | $2,060,000 | +13.6% | 1,492,771 | +8.6% | 0.58% | -24.8% |
| Q2 2022 | $1,814,000 | -67.0% | 1,374,098 | 0.0% | 0.76% | -13.0% |
| Q1 2022 | $5,496,000 | -52.5% | 1,374,098 | +21.0% | 0.88% | -79.1% |
| Q4 2021 | $11,569,000 | -28.8% | 1,135,365 | +13.0% | 4.20% | +2.4% |
| Q3 2021 | $16,251,000 | +49.2% | 1,005,000 | +19.9% | 4.10% | +5.3% |
| Q2 2021 | $10,890,000 | +3.9% | 838,311 | +54.4% | 3.90% | +9.6% |
| Q1 2021 | $10,480,000 | +24.4% | 543,010 | +34.7% | 3.56% | -20.3% |
| Q4 2020 | $8,427,000 | – | 403,000 | – | 4.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,658,199 | $2,189,000 | 0.84% |
| Affinity Asset Advisors, LLC | 1,374,098 | $1,814,000 | 0.76% |
| SABBY MANAGEMENT, LLC | 500,559 | $661,000 | 0.45% |
| TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $1,360,000 | 0.21% |
| Rubric Capital Management LP | 2,107,000 | $2,781,000 | 0.15% |
| Long Focus Capital Management, LLC | 980,000 | $1,294,000 | 0.14% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $508,000 | 0.09% |
| Clearline Capital LP | 452,184 | $597,000 | 0.08% |
| Sio Capital Management, LLC | 102,049 | $135,000 | 0.05% |
| Rock Springs Capital Management LP | 814,194 | $1,075,000 | 0.03% |